Navigation Links
Mosquito parasite may help fight dengue fever
Date:4/30/2009

Dengue fever is a terrible viral disease blighting many of the world's tropical regions. Carried by mosquitoes, such as Aedes aegypti, 40% of the world's population is believed to be at risk from the infection. What is more, previous exposure to other strains of the fever does not confer protection. In fact, subsequent infections are significantly worse, and can result in fatal dengue haemorrhagic fever. The lack of a functioning vaccine forced Scott O'Neill and Elizabeth McGraw to look for a more creative form of defence. Knowing that a parasite, Wolbachia pipientis, shortens the lifespan of host insects and could restrict dengue fever transmission by killing the insects before they can pass the infection on, O'Neill and his team successfully infected Ae. aegypti with a strain of the Wolbachia bacterium and shortened the mosquitoes' lifespan. But before insects carrying the bacterium can be released into the environment, the O'Neill and McGraw teams have to convince international governments that mosquitoes carrying the Wolbachia parasite could successfully limit transmission of the virus. McGraw and O'Neill had to find out how the bacterium affects the mosquito's physiology and behaviour and publish their results in the Journal of Experimental Biology on May 1 2009 at http://jeb.biologists.org.

Knowing that Wolbachia slows down some insects' activity and speeds up others, the team decided to test how the parasite affects Ae. aegypti as they age and the infection takes hold. Working with uninfected and infected mosquitoes produced by Conor McMeniman, Oliver Evans and Eric Caragata used a system designed by Craig Williams to film the activities of male and female mosquitoes as they aged to find how the bacteria affected the insects' activity levels. According to McGraw, the experiments generated a huge amount of video data, so Evans teamed up with Megan Woolfit and David
'/>"/>

Contact: Kathryn Knight
kathryn@biologists.com
44-122-342-5525
The Company of Biologists
Source:Eurekalert

Page: 1 2

Related biology news :

1. Advance in effort to fight malaria by tricking the mosquitos sense of smell
2. USDA Cooperative Agreement funds mosquito project at Rutgers
3. Earlier bites by uninfected mosquitoes boost West Nile deaths in lab mice
4. Researchers put the bite on mosquitoes
5. Netting mosquitoes to prevent malaria
6. Ayurvedic nightshade deadly for dengue mosquito
7. Pathway found that lets mosquitoes fatten up, slow down for winter
8. No more big stink: scent lures mosquitoes, but humans cant smell it
9. Mosquitoes create harmonic love song before mating, study finds
10. Hoarding rainwater could dramatically expand range of dengue-fever mosquito
11. Malaria immunity trigger found for multiple mosquito species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
(Date:2/5/2015)... North Carolina , 5. Februar 2015 ... Jahr als spezialisiertes Logistikunternehmen und hat eine ... einzige klinische Logistikfirma (Clinical Logistics Organization – ... der neuen Kampagne lautet First , ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... news release is available in Spanish . ... collaboration of university students analysed the effect of weekend alcohol consumption ... DNA. Until now, the damage to the packaging of nuclear material ... perhaps because most of the studies are done at later stages ...
... in the United States increased from 14.5% of the population ... believed that one contributing factor to expanding waistlines is the ... to control energy intake may be affected by the speed ... impair the relationship between the sensory signals and processes that ...
... The chitosan molecule can promote nerve cell adherence and ... enhance the adherence and influx of Schwann cells, thus ... by a nerve conduit may not be sufficient to ... Institute of Stomatology, Chinese PLA General Hospital in China ...
Cached Biology News:Alcohol leaves its mark on youngsters' DNA 2Alcohol leaves its mark on youngsters' DNA 3Slower-paced meal reduces hunger but affects calorie consumption differently 2Slower-paced meal reduces hunger but affects calorie consumption differently 3
(Date:3/4/2015)... 2015 Research and Markets ( ... PharmaBiotech,s new report "Biomarkers - Technologies, Markets ... This report follows the broad definition of ... objectively measured and evaluated as an indicator of ... pharmacological responses to a therapeutic intervention. Tests based ...
(Date:3/4/2015)... , March 4, 2015 AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... and breakthrough pain, today announced that it will ... after market close on Monday, March 9th, 2015. ... at 4:30 p.m. Eastern Time (1:30 p.m. Pacific ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
(Date:3/3/2015)... Experts and industry insiders from around the world ... REBELation exploring innovation, inspiration and world-changing ideas in Lexington, ... year, Alltech’s annual international conference traditionally draws more than ... join the REBELation at an extra discount registration closes ... which point the standard early registration rate will apply. ...
Breaking Biology Technology:Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... OncoGenex Pharmaceuticals, Inc (NASDAQ: OGXI ) will ... at the RBC Capital Markets 2008 Healthcare Conference on ... Westin Times Square Hotel in New York. During the ... Cormack, will provide a brief overview of the company,s ...
... ConjuChem,s, R&D Efforts -, ... BAGSVAERD, Denmark, Dec. 3 /PRNewswire-FirstCall/ - ConjuChem Biotechnologies Inc. ... Novozymes A/S (LSE:NVZ) announced today that the Companies have ... which Novozymes Biopharma will exclusively supply its recombinant human ...
... BioSciences, Inc., announced,today that it has expanded the ... Stent System with NanoThin Polyzene(R)-F -- a stent,system ... clinical studies. It is CE,Marked and available for ... with aggressive world-wide expansion ongoing. Concurrently,CeloNova notes that ...
Cached Biology Technology:ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 2ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 3CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3
Candida (IgA) -Ab EIA Sample Size: 5 l...
... Arabidopsis thaliana is the first higher plant ... serves as the primary model organism for ... content on this microarray is derived from ... for Genomic Research (TIGR) and from the ...
... with its manganese-containing reaction buffer, converts long ... short (1825 bp) interfering RNAs (siRNA) suitable ... units (1 l) of ShortCut RNase III ... dsRNA into siRNA suitable for RNA interference ...
EZ-Tn5™ Transposase is designed for use with our pMOD™ series of vectors as well as any EZ-Tn5™ transposon system....
Biology Products: